Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03789370
Other study ID # 06-11-14
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 7, 2014
Est. completion date October 30, 2020

Study information

Verified date November 2019
Source Attikon Hospital
Contact Chrysanthi Batistaki, MD, PhD
Phone 00302105832371
Email chrysabatistaki@yahoo.gr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Postoperative headache is a major issue after general anaesthesia and surgery. The aim of this study is to investigate the possible difference in the occurrence of postoperative headache when general anaesthesia is maintained with propofol, which is supposed to have protective effects on migraine patients, versus sevoflurane.


Description:

Postoperative headache is a major issue after general anaesthesia and surgery. The aim of this study is to investigate the possible difference in the occurrence of postoperative headache when general anaesthesia is maintained with propofol, versus sevoflurane. Propofol acts throught a GABA, and is known to have a therapeutic effect on migraine patients with accute attacts. However, its role on postoperative headache has not been studied, when used for maintainance of anaesthesia, this study aims to investigate the occurrence of headache after anaesthesia and surgery, when patients receive randomly two different anaesthetics: propofol and sevoflurane.


Recruitment information / eligibility

Status Recruiting
Enrollment 130
Est. completion date October 30, 2020
Est. primary completion date October 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- ASA I-III

- scheduled operation under general anaesthesia

- operations <4 hours

- minorgynaecological operatios (leiomyomectomy)

- hernia repair

- arthroscopic procedurs

- minor orthopaedic operations without the use of tourniquet or cement

- saphenectomy

- minor urologic operations

- minor other operations of general surgery

Exclusion Criteria:

- age <18 and >65 years old

- ASA>III

- Diseases of the central nervous system (ie Parkinsons's disease, Multiple sclerosis, previous ischaemic attack, hydrocephalus, seizure disorder, etc)

- Psychosis under medication

- Cognitive impairement or/and inability to fill in the questionaires

- Allergy or contraindication to the study protocol included drugs

- Operations of more than 4 hours duration

- Head and neck procedures, procedures with neck extension (eg thyroidectomy), ENT procedures

- renal impairement

- hepatic impairement

- patient refusal

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Propofol
Maintanance of general anaesthesia with propofol
Sevoflurane
Maintainance of general anaesthesia with sevoflurane.

Locations

Country Name City State
Greece 2nd Department of Anesthesiology, Attikon Hospital, 1 Rimini str. Athens

Sponsors (1)

Lead Sponsor Collaborator
Attikon Hospital

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary incidence of postoperative headache (yes or no) Rate of postoperative headache in patients receiving sevoflurane versus propofol (yes or no headache) up to 24 hours postoperatively
Secondary Nausea and vomiting Which anaesthetic (propofol or sevoflurane) is associated with less postoperative nausea and vomiting up to 24 hours postoperatively
See also
  Status Clinical Trial Phase
Withdrawn NCT03472872 - A Comparative Efficacy Trial of IV Acetaminophen Versus IV Ketorolac for Emergency Department Treatment of Generalized Headache Phase 4
Withdrawn NCT05410366 - Safe Harbors in Emergency Medicine, Specific Aim 3
Withdrawn NCT02866084 - Neuromodulation Treatment of Vestibular Migraines N/A
Active, not recruiting NCT03537573 - Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care N/A
Recruiting NCT05891808 - miR-155 Expression in Episodic and Chronic Migraine
Not yet recruiting NCT04352218 - Safety Profile of PETALO CVS in the Treatment of Non-thrombotic Internal Jugular Vein Stenosis and Chronic Headache Phase 2
Completed NCT02734992 - Acceptance and Commitment Therapy vs Medical Treatment as Usual Wait-list Control for Primary Headache Sufferers N/A
Completed NCT01153789 - Study of Oculomotor Dysfunction Leading to Children Vertigo N/A
Completed NCT01327118 - Prostaglandin F2alpha in a Human Headache Model N/A
Not yet recruiting NCT00969995 - Identification of Inflammatory Markers in Migraine Patients N/A
Not yet recruiting NCT00752921 - Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache Phase 4
Terminated NCT00291395 - PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers Phase 1
Completed NCT00212810 - Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache. Phase 4
Completed NCT00263094 - An End to the Yom Kippur (and Ramadan) Headache N/A
Completed NCT00135122 - Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache Phase 3
Completed NCT02475005 - An Intervention to Improve Adolescent Headache Self-management N/A
Completed NCT03163901 - The Effect of OMT on Functional Outcomes and Anti-inflammatory Biomarkers in Mild to Moderate Traumatic Brain Injury N/A
Completed NCT01664585 - Exercise Training With Physically Active Lifestyle to Reduce Headache and Quality of Life N/A
Completed NCT04632420 - Evaluation of Headache and Childbirth in a Chronic Pain Population
Recruiting NCT05033613 - Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease